Clear Lensectomy with Hydrus Stent in Black and Afro-Latino Patients: A 1-Year Retrospective Study

Purpose. To determine the efficacy and safety of phacoemulsification, clear lensectomy, and the Hydrus microstent (Ivantis, Inc.) in Black and Afro-Latino glaucoma patients. Method. This is a retrospective nonrandomized study of 134 Black and Afro-Latino patients who underwent clear lensectomy with...

Full description

Bibliographic Details
Main Authors: Daniel Laroche, Jessinta Oseni, Gideon Nkrumah, Chester Ng
Format: Article
Language:English
Published: Hindawi Limited 2022-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2022/8011745
_version_ 1797995181394362368
author Daniel Laroche
Jessinta Oseni
Gideon Nkrumah
Chester Ng
author_facet Daniel Laroche
Jessinta Oseni
Gideon Nkrumah
Chester Ng
author_sort Daniel Laroche
collection DOAJ
description Purpose. To determine the efficacy and safety of phacoemulsification, clear lensectomy, and the Hydrus microstent (Ivantis, Inc.) in Black and Afro-Latino glaucoma patients. Method. This is a retrospective nonrandomized study of 134 Black and Afro-Latino patients who underwent clear lensectomy with Hydrus stent implant for the treatment of glaucoma. For comprehensive analysis, patients were divided into mild, moderate, and advanced glaucoma. The evaluated parameters were reductions in the number of medications, intraocular pressure (IOP), mean deviation on visual field test, and visual acuity. Results. A total of 134 patients with 1-year follow-up were evaluated. At 1 year, the average number of medications significantly decreased from 2.5 ± 1.4 preoperatively to 0.43 ± 1.04 (p<0.001) and IOP decreased from 14.4 ± 3.9 to 13.8 ± 3.10 (p=0.16). 110 (82.1%) patients were medication-free at 1 year (n = 57, 83.8% mild glaucoma; n = 37, 92.5% moderate glaucoma; n = 16, 61.5% advanced glaucoma). There was stabilization of mean deviation on the visual field test (baseline, −8.28; 1 year, −8.28; p=1). The most reported adverse effects were transient IOP spike and hyphema (n = 7, 5.2%; n = 3, 2.2%, respectively); both events were self-resolving. No decline in vision or sight-threatening complications were reported at 1 year, and no additional surgeries were required. Conclusion. This 1-year retrospective study demonstrated the efficacy and safety of clear lensectomy and Hydrus stent implantation in decreasing medication burden while maintaining lower IOP in Black and Afro-Latino glaucoma patients.
first_indexed 2024-04-11T09:57:21Z
format Article
id doaj.art-7dffd63b60b34a469ac0be0e4311aa68
institution Directory Open Access Journal
issn 2090-0058
language English
last_indexed 2024-04-11T09:57:21Z
publishDate 2022-01-01
publisher Hindawi Limited
record_format Article
series Journal of Ophthalmology
spelling doaj.art-7dffd63b60b34a469ac0be0e4311aa682022-12-22T04:30:32ZengHindawi LimitedJournal of Ophthalmology2090-00582022-01-01202210.1155/2022/8011745Clear Lensectomy with Hydrus Stent in Black and Afro-Latino Patients: A 1-Year Retrospective StudyDaniel Laroche0Jessinta Oseni1Gideon Nkrumah2Chester Ng3Department of OphthalmologyAlbert Einstein College of MedicineUniversity of PittsburghAdvanced Eyecare of New YorkPurpose. To determine the efficacy and safety of phacoemulsification, clear lensectomy, and the Hydrus microstent (Ivantis, Inc.) in Black and Afro-Latino glaucoma patients. Method. This is a retrospective nonrandomized study of 134 Black and Afro-Latino patients who underwent clear lensectomy with Hydrus stent implant for the treatment of glaucoma. For comprehensive analysis, patients were divided into mild, moderate, and advanced glaucoma. The evaluated parameters were reductions in the number of medications, intraocular pressure (IOP), mean deviation on visual field test, and visual acuity. Results. A total of 134 patients with 1-year follow-up were evaluated. At 1 year, the average number of medications significantly decreased from 2.5 ± 1.4 preoperatively to 0.43 ± 1.04 (p<0.001) and IOP decreased from 14.4 ± 3.9 to 13.8 ± 3.10 (p=0.16). 110 (82.1%) patients were medication-free at 1 year (n = 57, 83.8% mild glaucoma; n = 37, 92.5% moderate glaucoma; n = 16, 61.5% advanced glaucoma). There was stabilization of mean deviation on the visual field test (baseline, −8.28; 1 year, −8.28; p=1). The most reported adverse effects were transient IOP spike and hyphema (n = 7, 5.2%; n = 3, 2.2%, respectively); both events were self-resolving. No decline in vision or sight-threatening complications were reported at 1 year, and no additional surgeries were required. Conclusion. This 1-year retrospective study demonstrated the efficacy and safety of clear lensectomy and Hydrus stent implantation in decreasing medication burden while maintaining lower IOP in Black and Afro-Latino glaucoma patients.http://dx.doi.org/10.1155/2022/8011745
spellingShingle Daniel Laroche
Jessinta Oseni
Gideon Nkrumah
Chester Ng
Clear Lensectomy with Hydrus Stent in Black and Afro-Latino Patients: A 1-Year Retrospective Study
Journal of Ophthalmology
title Clear Lensectomy with Hydrus Stent in Black and Afro-Latino Patients: A 1-Year Retrospective Study
title_full Clear Lensectomy with Hydrus Stent in Black and Afro-Latino Patients: A 1-Year Retrospective Study
title_fullStr Clear Lensectomy with Hydrus Stent in Black and Afro-Latino Patients: A 1-Year Retrospective Study
title_full_unstemmed Clear Lensectomy with Hydrus Stent in Black and Afro-Latino Patients: A 1-Year Retrospective Study
title_short Clear Lensectomy with Hydrus Stent in Black and Afro-Latino Patients: A 1-Year Retrospective Study
title_sort clear lensectomy with hydrus stent in black and afro latino patients a 1 year retrospective study
url http://dx.doi.org/10.1155/2022/8011745
work_keys_str_mv AT daniellaroche clearlensectomywithhydrusstentinblackandafrolatinopatientsa1yearretrospectivestudy
AT jessintaoseni clearlensectomywithhydrusstentinblackandafrolatinopatientsa1yearretrospectivestudy
AT gideonnkrumah clearlensectomywithhydrusstentinblackandafrolatinopatientsa1yearretrospectivestudy
AT chesterng clearlensectomywithhydrusstentinblackandafrolatinopatientsa1yearretrospectivestudy